8Wilder J L, Shajahan S, Khattar N H, et al. Tamoxifenasso-ciated malignant endometrial tumors, pathologic features and expressionofhormone receptors estrogen-alpha, estrogen-beta and progesterone: A case controlled study[ J]. Gynecol Oncol,2004,92(2) :553-558.
9Joseph G, Kathleen P, Paul G, et al. Adjuvant and extended adjuvant use of aromatase inhibitors: Reducing the risk of recurrence and distant metastasis[ J]. The Breast,2007,16 :S1-S9.
10The Aximidex, Tamoxifen, Alone or in Combinaiton (ATAC) Trialists' Group. Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer [ J ]. Lancet Oncol,2006,7:633-643.
2Novosyadlyy R, LeRoith D. Hyperinsulinemia and type 2 diabetes. Cell Cycle ,2010,98 : 1449-1450.
3Vigneri P, Frasca F, Sciacca L, et al. Diabetes and cancer. Endocr Relat Cancer,2009,16 : 1103-1123.
4Chowdhury TA. Diabetes and cancer. QJM ,2010,103:905-915.
5Nussbanm T, Samarin J, Ehemann V, et al. Autocrine insulin-like growth factor-II stimulation of tumor cellmigration is a progression step in human hepatocarcinogenesis. Hepatology,2008,48 : 146-156.
6Sandra Braun, Keren Bitton-Worms, Derek LeRoith. The Link between the Metabolic Syndrome and Cancer. Int J Biol Sci,2011,7:1003-1015.
7Chodick G, Heymann AD, Rosenmann L,et al. Diabetes and risk of inci- dent cancer: a large population-based cohort study in Israel. Cancer Cau- ses Control,2010,21:879-887.
8Hanbali A. Protective effect of diabetes against metastasis in patients with non-small cell lung cancer. Arch Int Med,2007 ,167 :513.
9Grote A, Becket S, Kaaks R. Diabetes mellitus type 2-anindependen- trisk factor for cancer. Exp Clin Endocrinol Diabetes ,2010,118:4-8.
